Geneos Wealth Management Inc. T2 Biosystems, Inc. Transaction History

Geneos Wealth Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.09 - $565.0 $2,250 - $14.1 Million	-25,000 Reduced 30.86%	56,000 $6,000
Q3 2021 Nov 09, 2021	BUY	$0.86 - $1.21 $12,040 - $16,940	14,000 Added 20.9%	81,000 $75,000
Q2 2021 Jul 08, 2021	BUY	$1.04 - $1.69 $69,680 - $113,230	67,000 New	67,000 $75,000
Q4 2020 May 19, 2021	SELL	$1.06 - $1.51 $5,300 - $7,550	-5,000 Closed	0 $0
Q3 2020 Sep 07, 2021	BUY	$1.15 - $2.1 $5,750 - $10,500	5,000 New	5,000 $5,000
Q1 2017 Sep 07, 2021	SELL	N/A	-1,915 Closed	0 $0
Q4 2016 Sep 07, 2021	BUY	N/A	1,915	1,915 $10,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.